Apellis Pharmaceuticals, Inc. (APLS)

Apellis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	466.23	411.29	351.19	551.8	640.19
Short-Term Investments	1.55	4.85	4.35	6.51	61.04
Cash & Short-Term Investments	467.79	416.14	355.54	558.31	701.23
Cash Growth	12.41%	17.04%	-36.32%	-20.38%	-20.10%
Accounts Receivable	369.16	271.72	224.5	29.17	80.1
Other Receivables	-	-	-	8.71	-
Receivables	369.16	271.72	224.5	37.88	80.1
Inventory	144.76	82.48	162.66	99.7	24
Prepaid Expenses	9.52	9.51	8.59	7.18	5.17
Restricted Cash	1.53	1.32	1.11	1.27	1.56
Other Current Assets	22.1	7.78	13.93	15.18	11.98
Total Current Assets	1,015	788.95	766.33	719.52	824.05
Property, Plant & Equipment	19.9	19.04	21.09	24.9	26.08
Long-Term Accounts Receivable	-	-	-	15	30
Other Long-Term Assets	40.51	77.06	1.31	0.8	1.64
Total Assets	1,075	885.05	788.73	760.22	881.77
Accounts Payable	56.8	38.57	37.52	37.34	16.91
Accrued Expenses	166.05	140.18	127.81	95.14	103.24
Current Portion of Long-Term Debt	93.66	-	-	-	-
Current Portion of Leases	7.09	6.75	6.44	5.63	4.12
Other Current Liabilities	-	-	75.83	29.5	7.58
Total Current Liabilities	323.6	185.51	247.59	167.61	131.85
Long-Term Debt	361.66	452.83	93.03	92.74	189.02
Long-Term Leases	11.95	10.2	11.45	14.35	17.08
Other Long-Term Liabilities	7.9	7.97	242.13	315.65	345.15
Total Liabilities	705.11	656.51	594.21	590.35	683.1
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	3,385	3,267	3,036	2,480	1,857
Retained Earnings	-3,013	-3,035	-2,837	-2,309	-1,657
Comprehensive Income & Other	-2.1	-3.31	-3.54	-0.88	-2.09
Total Common Equity	370.15	228.54	194.52	169.87	198.66
Shareholders' Equity	370.15	228.54	194.52	169.87	198.66
Total Liabilities & Equity	1,075	885.05	788.73	760.22	881.77
Total Debt	474.36	469.78	110.93	112.71	210.22
Net Cash (Debt)	-6.57	-53.65	244.61	445.59	491.01
Net Cash Growth	-	-	-45.10%	-9.25%	-1.78%
Net Cash Per Share	-0.05	-0.43	2.06	4.20	5.82
Filing Date Shares Outstanding	127.83	125.52	120.58	111.29	97.73
Total Common Shares Outstanding	126.62	124.5	119.56	110.77	97.52
Working Capital	691.24	603.45	518.74	551.91	692.2
Book Value Per Share	2.92	1.84	1.63	1.53	2.04
Tangible Book Value	370.15	228.54	194.52	169.87	198.66
Tangible Book Value Per Share	2.92	1.84	1.63	1.53	2.04

Updated Feb 24, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q